Nifty
Sensex
:
:
17138.10
57515.13
-479.05 (-2.72%)
-1522.05 (-2.58%)

Pharmaceuticals & Drugs - Domestic

Rating :
63/99

BSE: 506943 | NSE: JBCHEPHARM

1760.40
21-Jan-2022
  • Open
  • High
  • Low
  • Previous Close
  •  1750.00
  •  1766.00
  •  1725.00
  •  1750.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  48734
  •  854.17
  •  1985.00
  •  956.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 13,600.10
  • 28.94
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 13,601.90
  • 0.94%
  • 6.89

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.00%
  • 0.75%
  • 18.38%
  • FII
  • DII
  • Others
  • 9.12%
  • 16.03%
  • 1.72%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.80
  • 8.34
  • 7.52

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.68
  • 19.07
  • 12.70

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -4.06
  • 19.47
  • 32.29

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.13
  • 17.95
  • 20.90

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.80
  • 3.32
  • 4.16

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.49
  • 12.19
  • 13.70

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Net Sales
593.01
443.56
33.69%
605.99
522.29
16.03%
528.46
443.57
19.14%
548.22
428.63
27.90%
Expenses
466.27
333.47
39.82%
442.31
366.86
20.57%
404.56
351.83
14.99%
377.22
339.04
11.26%
EBITDA
126.74
110.10
15.11%
163.68
155.42
5.31%
123.90
91.74
35.06%
170.99
89.59
90.86%
EBIDTM
21.37%
24.82%
27.01%
29.76%
23.44%
20.68%
31.19%
20.90%
Other Income
19.64
8.39
134.09%
12.97
22.69
-42.84%
25.35
3.17
699.68%
55.95
16.38
241.58%
Interest
1.22
1.72
-29.07%
0.94
3.75
-74.93%
0.69
0.50
38.00%
1.09
0.85
28.24%
Depreciation
15.73
17.45
-9.86%
17.85
17.29
3.24%
16.53
17.39
-4.95%
17.39
16.75
3.82%
PBT
129.43
99.33
30.30%
157.87
157.07
0.51%
132.02
67.02
96.99%
208.46
88.37
135.89%
Tax
31.54
25.41
24.12%
38.81
37.57
3.30%
31.21
16.95
84.13%
54.18
21.93
147.06%
PAT
97.89
73.92
32.43%
119.06
119.51
-0.38%
100.81
50.07
101.34%
154.28
66.45
132.17%
PATM
16.51%
16.67%
19.65%
22.88%
19.08%
11.29%
28.14%
15.50%
EPS
12.65
9.55
32.46%
15.38
15.45
-0.45%
13.02
6.49
100.62%
19.94
8.26
141.40%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
2,275.68
2,042.52
1,774.73
1,643.20
1,413.77
1,368.32
1,231.58
1,144.21
1,021.86
866.13
801.87
Net Sales Growth
23.81%
15.09%
8.00%
16.23%
3.32%
11.10%
7.64%
11.97%
17.98%
8.01%
 
Cost Of Goods Sold
805.50
701.50
630.80
596.46
542.41
552.00
491.41
341.40
413.95
371.52
320.07
Gross Profit
1,470.18
1,341.02
1,143.93
1,046.74
871.35
816.32
740.17
802.81
607.92
494.60
481.80
GP Margin
64.60%
65.66%
64.46%
63.70%
61.63%
59.66%
60.10%
70.16%
59.49%
57.10%
60.08%
Total Expenditure
1,690.36
1,486.35
1,397.15
1,337.36
1,214.64
1,135.93
1,025.55
964.09
873.67
760.48
701.55
Power & Fuel Cost
-
62.60
61.54
63.29
58.28
54.89
55.28
53.02
46.61
39.75
29.89
% Of Sales
-
3.06%
3.47%
3.85%
4.12%
4.01%
4.49%
4.63%
4.56%
4.59%
3.73%
Employee Cost
-
340.60
322.92
288.18
251.10
217.34
175.31
159.56
143.67
130.05
112.66
% Of Sales
-
16.68%
18.20%
17.54%
17.76%
15.88%
14.23%
13.94%
14.06%
15.02%
14.05%
Manufacturing Exp.
-
148.68
140.70
150.49
139.83
131.45
119.35
223.53
102.44
61.75
52.97
% Of Sales
-
7.28%
7.93%
9.16%
9.89%
9.61%
9.69%
19.54%
10.02%
7.13%
6.61%
General & Admin Exp.
-
43.27
48.14
52.97
53.96
42.26
34.82
32.46
31.69
27.94
31.31
% Of Sales
-
2.12%
2.71%
3.22%
3.82%
3.09%
2.83%
2.84%
3.10%
3.23%
3.90%
Selling & Distn. Exp.
-
113.22
116.95
113.59
87.44
78.27
72.72
75.13
73.59
56.04
68.65
% Of Sales
-
5.54%
6.59%
6.91%
6.18%
5.72%
5.90%
6.57%
7.20%
6.47%
8.56%
Miscellaneous Exp.
-
76.46
76.11
72.38
81.61
59.72
76.65
79.01
61.72
73.44
68.65
% Of Sales
-
3.74%
4.29%
4.40%
5.77%
4.36%
6.22%
6.91%
6.04%
8.48%
10.72%
EBITDA
585.31
556.17
377.58
305.84
199.13
232.39
206.03
180.12
148.19
105.65
100.32
EBITDA Margin
25.72%
27.23%
21.28%
18.61%
14.09%
16.98%
16.73%
15.74%
14.50%
12.20%
12.51%
Other Income
113.91
116.62
50.90
41.44
55.29
50.16
56.65
10.89
37.70
27.87
28.98
Interest
3.94
7.24
3.26
4.65
3.49
5.37
10.65
6.82
5.93
5.28
24.03
Depreciation
67.50
68.67
66.32
55.64
56.97
47.22
41.22
38.64
28.02
24.66
22.42
PBT
627.78
596.89
358.89
286.99
193.95
229.94
210.82
145.55
151.94
103.57
82.85
Tax
155.74
148.36
76.50
93.02
55.23
45.55
49.58
45.14
25.95
24.13
165.53
Tax Rate
24.81%
24.86%
21.93%
32.41%
28.48%
19.81%
23.52%
31.01%
29.68%
23.30%
19.63%
PAT
472.04
447.96
272.04
193.47
138.34
184.06
161.14
100.41
61.50
79.44
677.91
PAT before Minority Interest
471.34
448.52
272.39
193.97
138.72
184.40
161.24
100.41
61.50
79.44
677.91
Minority Interest
-0.70
-0.56
-0.35
-0.50
-0.38
-0.34
-0.10
0.00
0.00
0.00
0.00
PAT Margin
20.74%
21.93%
15.33%
11.77%
9.79%
13.45%
13.08%
8.78%
6.02%
9.17%
84.54%
PAT Growth
52.30%
64.67%
40.61%
39.85%
-24.84%
14.22%
60.48%
63.27%
-22.58%
-88.28%
 
EPS
61.07
57.95
35.19
25.03
17.90
23.81
20.85
12.99
7.96
10.28
87.70

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
1,809.72
1,435.49
1,480.12
1,441.56
1,363.67
1,183.84
994.87
1,042.81
1,020.27
969.95
Share Capital
15.46
15.46
16.05
16.71
16.96
16.96
16.96
16.95
16.94
16.94
Total Reserves
1,794.27
1,420.03
1,464.08
1,424.84
1,346.70
1,166.87
977.91
1,025.82
1,003.22
952.83
Non-Current Liabilities
72.47
62.72
64.84
45.66
26.98
31.02
32.62
31.93
40.45
39.52
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.09
0.22
0.40
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.40
0.40
7.03
12.14
Long Term Provisions
12.57
7.39
5.73
9.67
12.56
10.43
12.03
12.19
8.23
8.27
Current Liabilities
686.57
516.19
781.54
736.50
693.46
797.22
459.75
276.27
239.48
188.32
Trade Payables
186.92
167.97
117.37
110.39
98.98
90.85
77.51
60.75
60.51
37.09
Other Current Liabilities
89.82
102.67
93.10
119.75
122.15
138.73
103.74
98.06
101.15
78.75
Short Term Borrowings
32.64
29.49
25.80
29.29
48.86
193.02
126.88
81.71
37.28
55.23
Short Term Provisions
377.17
216.06
545.27
477.06
423.47
374.61
151.62
35.76
40.54
17.26
Total Liabilities
2,572.47
2,016.90
2,329.30
2,226.49
2,086.29
2,013.75
1,487.24
1,351.01
1,300.20
1,197.79
Net Block
633.65
651.26
620.93
639.50
679.44
440.22
328.56
310.55
334.41
276.31
Gross Block
1,182.55
1,177.43
1,084.83
1,053.76
1,038.55
753.75
601.67
540.54
537.46
456.51
Accumulated Depreciation
548.90
526.17
463.89
414.25
359.10
313.53
273.11
229.99
203.06
180.19
Non Current Assets
678.57
740.83
740.80
717.89
879.15
831.58
586.31
370.37
356.49
331.58
Capital Work in Progress
25.57
16.17
15.09
17.40
3.76
134.89
55.17
46.36
4.81
39.00
Non Current Investment
12.91
69.45
95.88
49.96
185.84
231.42
184.83
2.75
2.99
3.00
Long Term Loans & Adv.
5.62
3.59
8.31
10.15
9.43
22.63
17.74
10.71
14.28
13.27
Other Non Current Assets
0.82
0.36
0.59
0.88
0.67
2.43
0.00
0.00
0.00
0.00
Current Assets
1,893.89
1,276.08
1,588.51
1,508.59
1,207.14
1,182.16
900.94
980.65
943.71
866.22
Current Investments
664.97
333.81
360.65
383.77
224.96
247.28
366.78
497.26
394.68
298.92
Inventories
347.45
274.67
243.76
213.73
200.17
187.98
150.27
134.40
104.53
101.03
Sundry Debtors
389.02
345.43
308.22
300.73
265.97
272.64
262.35
235.51
191.27
136.05
Cash & Bank
30.85
30.95
36.80
29.92
13.39
12.90
25.19
11.81
156.23
219.53
Other Current Assets
461.61
18.89
33.23
12.94
502.66
461.34
96.35
101.68
96.99
110.69
Short Term Loans & Adv.
436.39
272.33
605.85
567.50
488.30
458.83
95.97
101.48
96.84
110.29
Net Current Assets
1,207.33
759.88
806.97
772.10
513.68
384.94
441.19
704.37
704.23
677.90
Total Assets
2,572.46
2,016.91
2,329.31
2,226.48
2,086.29
2,013.74
1,487.25
1,351.02
1,300.20
1,197.80

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
314.78
275.75
194.33
122.92
201.13
140.41
126.66
-13.98
84.20
879.69
PBT
596.89
348.89
286.99
193.95
229.94
212.23
145.55
87.44
103.57
843.44
Adjustment
-46.17
7.95
23.72
16.91
13.11
-1.40
38.51
20.75
-4.40
33.13
Changes in Working Capital
-94.21
9.70
-51.47
-47.07
5.92
-16.96
-19.52
-93.71
9.47
167.35
Cash after chg. in Working capital
456.50
366.55
259.24
163.79
248.97
193.88
164.53
14.49
108.65
1,043.91
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-141.72
-90.80
-64.91
-40.87
-47.84
-53.47
-37.87
-28.47
-24.45
-164.22
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-230.68
23.93
-27.67
-20.68
-45.31
-27.62
-111.89
-142.50
-116.05
-260.92
Net Fixed Assets
-12.39
-94.42
-29.82
-29.56
-152.86
-187.76
-69.64
-55.43
-41.77
-69.55
Net Investments
-274.62
53.26
-22.80
-22.92
67.89
-14.16
-61.38
-102.46
-95.95
-214.42
Others
56.33
65.09
24.95
31.80
39.66
174.30
19.13
15.39
21.67
23.05
Cash from Financing Activity
-87.42
-306.05
-155.74
-59.52
-183.84
-99.62
-1.39
12.04
-31.45
-526.12
Net Cash Inflow / Outflow
-3.31
-6.38
10.92
42.72
-28.02
13.17
13.38
-144.43
-63.30
92.65
Opening Cash & Equivalents
25.75
32.14
21.24
-21.47
6.54
-5.46
11.81
156.23
219.53
126.89
Closing Cash & Equivalent
22.47
25.75
32.14
21.24
-21.47
9.42
25.19
11.81
156.23
219.53

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
234.17
185.75
184.47
172.50
160.77
139.57
117.31
123.07
119.21
113.34
ROA
19.55%
12.53%
8.52%
6.43%
8.99%
9.21%
7.08%
4.64%
6.36%
61.71%
ROE
27.64%
18.69%
13.28%
9.89%
14.48%
14.80%
9.86%
5.99%
8.07%
82.49%
ROCE
36.53%
23.71%
19.59%
13.70%
16.87%
17.72%
13.49%
8.50%
10.41%
92.09%
Fixed Asset Turnover
1.73
1.57
1.54
1.35
1.53
1.82
2.03
1.92
1.76
1.85
Receivable days
65.62
67.22
67.63
73.15
71.84
79.28
78.41
75.30
68.16
108.62
Inventory Days
55.59
53.31
50.81
53.43
51.77
50.12
44.83
42.16
42.80
47.97
Payable days
43.67
38.74
32.21
33.66
32.86
32.45
27.82
26.91
26.15
26.89
Cash Conversion Cycle
77.54
81.79
86.23
92.93
90.75
96.95
95.43
90.54
84.81
129.69
Total Debt/Equity
0.02
0.02
0.02
0.02
0.04
0.16
0.13
0.09
0.05
0.07
Interest Cover
83.43
108.09
62.74
56.54
43.81
20.80
22.33
15.74
20.61
36.10

News Update:


  • JB Chemicals & Pharmaceuticals to launch Molnupiravir 200 mg for Indian market
    29th Dec 2021, 09:33 AM

    Molnupiravir should be administered as soon as possible after a diagnosis of COVID-19 has been made, and within five days of symptom onset

    Read More
  • JB Chem & Pharma - Quarterly Results
    11th Nov 2021, 18:43 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.